<i>In Vitro</i> Adenosine Triphosphate-Based Chemotherapy Response Assay as a Predictor of Clinical Response to Fluorouracil-Based Adjuvant Chemotherapy in Stage II Colorectal Cancer-Reference-Cited by-同舟云学术

In Vitro Adenosine Triphosphate-Based Chemotherapy Response Assay as a Predictor of Clinical Response to Fluorouracil-Based Adjuvant Chemotherapy in Stage II Colorectal Cancer

Published:2016-07-15 Issue:3 Volume:48 Page:970-977
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Kwon Hye Youn,Kim Im-kyung,Kang Jeonghyun,Sohn Seung-Kook,Lee Kang Young

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2015-140.pdf

Reference25 articles.

1. Primary Bioassay of Human Tumor Stem Cells

2. In Vitro Growth of Human Malignancies in a Cloning Assay

3. Chemosensitivity testing with highly purified fresh human tumour cells with the MTT colorimetric assay

4. In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture.

5. A Feasibility Study of Adenosine Triphosphate-based Chemotherapy Response Assay (ATP-CRA) as a Chemosensitivity Test for Lung Cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemosensitivity analysis and study of gene resistance on tumors and cancer stem cell isolates from patients with colorectal cancer;Molecular Medicine Reports;2021-08-11

2. METHODOLOGICAL APPROACHES TO THE DETERMINATION OF CHEMORESISTANCE OF HUMAN CANCER CELLS TO ANTI-CANCER DRUGS;Siberian journal of oncology;2020-07-06

3. Sample preparation strategies for high-throughput mass spectrometry imaging of primary tumor organoids;Journal of Mass Spectrometry;2020-01-21

4. Inhibition of hydrogen sulfide synthesis reverses acquired resistance to 5-FU through miR-215-5p-EREG/TYMS axis in colon cancer cells;Cancer Letters;2019-12

5. Adenosine triphosphate-based chemotherapy response assay predicts long-term survival of primary epithelial ovarian cancer;International Journal of Gynecologic Cancer;2019-01-04